rx 821002 has been researched along with 4-iodoclonidine in 1 studies
Studies (rx 821002) | Trials (rx 821002) | Recent Studies (post-2010) (rx 821002) | Studies (4-iodoclonidine) | Trials (4-iodoclonidine) | Recent Studies (post-2010) (4-iodoclonidine) |
---|---|---|---|---|---|
317 | 0 | 45 | 43 | 2 | 10 |
Protein | Taxonomy | rx 821002 (IC50) | 4-iodoclonidine (IC50) |
---|---|---|---|
Alpha-2A adrenergic receptor | Homo sapiens (human) | 0.0015 | |
Alpha-2B adrenergic receptor | Homo sapiens (human) | 0.0015 | |
Alpha-2C adrenergic receptor | Homo sapiens (human) | 0.0015 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Muskardin, DT; Wallace, DR; Zahniser, NR | 1 |
1 other study(ies) available for rx 821002 and 4-iodoclonidine
Article | Year |
---|---|
Pharmacological characterization of [3H]idazoxan, [3H]RX821002 and p-[125I]iodoclonidine binding to alpha 2-adrenoceptors in rat cerebral cortical membranes.
Topics: Adrenergic alpha-Antagonists; Affinity Labels; Animals; Binding, Competitive; Cerebral Cortex; Clonidine; Dioxanes; Idazoxan; Male; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-2 | 1994 |